Guidelines: Finnish Breast Cancer Association Guideline (Finland)

From Beacon
Revision as of 13:34, 2 December 2025 by Lucas (talk | contribs) (Update categories.)

forproviders forpolicymakers Go back to Finland page

Primary purpose: To provide comprehensive, evidence-based recommendations for the diagnosis, treatment, and follow-up care of breast cancer patients to ensure optimal patient outcomes and standardized clinical practices.

Sponsor, manager or home institution: Finnish Breast Cancer Group.

Type of information: medical procedures, screening, cancer prevalence, risk of cancer, palliative care. Provides comprehensive guidelines on breast cancer, covering diagnostic pathways, staging, triple diagnostics, imaging follow-up, hereditary breast cancer, core needle biopsy, multidisciplinary treatment planning, surgical and reconstruction options, radiotherapy, neoadjuvant and adjuvant drug treatments, hormonal therapies, chemotherapy, management of recurrent and metastatic breast cancer, special cases like pregnancy, and follow-up care. Click here to learn more.

Cancer areas of interest: C50: Breast cancer. Click here to learn more.

Access to information: Click here to access.

Lobular Breast Nipple Areola Ductal dataOwner::Finnish Breast Cancer Group availableVariable::medical procedures availableVariable::screening availableVariable::cancer prevalence availableVariable::risk of cancer availableVariable::palliative care hasCancerType::C50: Breast cancer